Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
International Journal of Clinical Pharmacy
Published in: International Journal of Clinical Pharmacy 1/2022

01-02-2022 | Antidepressant Drugs | Research Article

The role of community pharmacists in depression management: a survey of attitudes, practices and perceived barriers

Authors: Rula Shami, Mohammed Fasihul Alam, Maguy Saffouh ElHajj

Published in: International Journal of Clinical Pharmacy | Issue 1/2022

Login to get access

Abstract

Background Community pharmacists play a significant role in depression care. Depression is a health priority in national health strategies around the world, including in Qatar. Objective To describe current practices, attitudes and perceived barriers of community pharmacists towards depression care, and to investigate factors associated with these practices. Setting Community pharmacies in Qatar. Method A cross-sectional online survey using an adapted survey instrument. Scores were measured on a five-point Likert scale. Descriptive univariate and bivariate analyses of study outcomes, followed by multivariate regression examining the association between pharmacists’ practices and their attitudes, socio-demographic and professional characteristics. Main outcome measure Pharmacists’ scores on self-reported attitudes towards depression and depression care practices and the number of perceived barriers for depression care. Result: 358 pharmacists (response rate 39%) completed the questionnaire. Pharmacists’ attitudes to depression were moderately positive (mean score = 3.41, SD = 0.26) but involvement in depression care was very low (mean score = 2.64, SD = 0.94). Three major barriers were lack of access to patients’ medical records (83.21%), lack of patients’ insight on depression and the importance of treatment (81.85%), and lack of knowledge and training on mental health (79.63%). Female pharmacists and those graduated more than 10 years prior were significantly less involved in depression care compared to their counterparts (practice scores (95% CI) −4.36 (−7.46 to −1.26) and -7.51 (−15.10 to −1.35), respectively), while those who had access to private counselling area were more involved (practice score 3.39 (0.20 to 6.59). Pharmacists’ depression practice score was positively associated with attitudes (p = 0.001). Conclusion Pharmacists’ moderately positive attitudes were not reflected in their suboptimal depression-care practices. Action from policymakers is needed to improve pharmacists’ practices and attitudes to depression.
Appendix
Available only for authorised users
Literature
1.
2.
Zolezzi M, Alamri M, Shaar S, Rainkie D. Stigma associated with mental illness and its treatment in the Arab culture: A systematic review. Int J Soc Psychiatry. 2018;64(6):597–609.PubMedCrossRef
3.
4.
Kohn R, Saxena S, Levav I, Saraceno B. The treatment gap in mental health care. Bull World Health Organ. 2004;82(11):858–66.PubMedPubMedCentral
5.
Bener A, Abou-Saleh MT, Dafeeah EE, Bhugra D. The prevalence and burden of psychiatric disorders in primary health care visits in qatar: too little time? J Family Med Prim Care. 2015;4(1):89–95.PubMedPubMedCentralCrossRef
6.
Dhar AK, Barton DA. Depression and the Link with Cardiovascular Disease. Front Psychiatry. 2016;7:33.
7.
8.
9.
10.
Cleare A, Pariante CM, Young AH, Anderson IM, Christmas D, Cowen PJ, et al. Evidence-based guidelines for treating depressive disorders with antidepressants: a revision of the 2008 British Association for Psychopharmacology guidelines. J Psychopharmacol. 2015;29(5):459–525.PubMedCrossRef
11.
Baldessarini RJ, Lau WK, Sim J, Sum MY, Sim K. Duration of initial antidepressant treatment and subsequent relapse of major depression. J Clin Psychopharmacol. 2015;35(1):75–6.PubMedCrossRef
12.
DiMatteo MR, Lepper HS, Croghan TW. Depression is a risk factor for noncompliance with medical treatment: meta-analysis of the effects of anxiety and depression on patient adherence. Arch Intern Med. 2000;160(14):2101–7.PubMedCrossRef
13.
Kates N, Mach M. Chronic disease management for depression in primary care: a summary of the current literature and implications for practice. Can J Psychiatry. 2007;52(2):77–85.PubMedCrossRef
14.
Capoccia KL, Boudreau DM, Blough DK, Ellsworth AJ, Clark DR, Stevens NG, et al. Randomized trial of pharmacist interventions to improve depression care and outcomes in primary care. Am J Health Syst Pharm. 2004;61(4):364–72.PubMedCrossRef
15.
McMillan SS, Kelly F, Hattingh HL, Fowler JL, Mihala G, Wheeler AJ. The impact of a person-centred community pharmacy mental health medication support service on consumer outcomes. J Ment Health. 2018;27(2):164–73.PubMedCrossRef
16.
Brown JVE, Walton N, Meader N, Todd A, Webster LA, Steele R, et al. Pharmacy-based management for depression in adults. Cochrane Database Syst Rev. 2019;12(12):013299.
17.
Brook O, van Hout H, Nieuwenhuyse H, Heerdink E. Impact of coaching by community pharmacists on drug attitude of depressive primary care patients and acceptability to patients; a randomized controlled trial. Eur Neuropsychopharmacol. 2003;13(1):1–9.PubMedCrossRef
18.
Aljumah K, Hassali MA. Impact of pharmacist intervention on adherence and measurable patient outcomes among depressed patients: a randomised controlled study. BMC Psychiatry. 2015;15:219.PubMedPubMedCentralCrossRef
19.
Al-Saffar N, Abdulkareem A, Abdulhakeem A, Salah AQ, Heba M. Depressed patients’ preferences for education about medications by pharmacists in Kuwait. Patient Educ Couns. 2008;72(1):94–101.PubMedCrossRef
20.
Melton BL, Lai Z. Review of community pharmacy services: what is being performed, and where are the opportunities for improvement? Integr Pharm Res Pract. 2017;6:79–89.PubMedPubMedCentralCrossRef
21.
22.
Ghuloum S, Bener A, Abou-Saleh MT. Prevalence of mental disorders in adult population attending primary health care setting in Qatari population. J Pak Med Assoc. 2011;61(3):216–21.PubMed
23.
24.
25.
Gilbody S, Bower P, Fletcher J, Richards D, Sutton AJ. Collaborative care for depression: a cumulative meta-analysis and review of longer-term outcomes. Arch Intern Med. 2006;166(21):2314–21.PubMedCrossRef
26.
27.
28.
29.
Sadek MM, Elnour AA, Al Kalbani NM, Bhagavathula AS, Baraka MA, Aziz AM, et al. Community pharmacy and the extended community pharmacist practice roles: the UAE experiences. Saudi Pharm J. 2016;24(5):563–70.PubMedCrossRef
30.
El Hajj MS, Awaisu A, Kheir N, Mohamed MHN, Haddad RS, Saleh RA, et al. Evaluation of an intensive education program on the treatment of tobacco-use disorder for pharmacists: a study protocol for a randomized controlled trial. Trials. 2019;20(1):25.PubMedPubMedCentralCrossRef
31.
El Hajj MS, Kheir N, Al Mulla AM, Shami R, Fanous N, Mahfoud ZR. Effectiveness of a pharmacist-delivered smoking cessation program in the State of Qatar: a randomized controlled trial. BMC Public Health. 2017;17(1):215.PubMedPubMedCentralCrossRef
32.
Rubio-Valera M, Chen TF, O’Reilly CL. New roles for pharmacists in community mental health care: a narrative review. Int J Environ Res Public Health. 2014;11(10):10967–90.PubMedPubMedCentralCrossRef
33.
34.
ASHP 1999 ASHP statement on the pharmacist's role in primary care. Am J Health Syst Pharm. 56(16):1665–1667.
35.
36.
Cannon-Breland ML, Westrick SC, Kavookjian J, Berger BA, Shannon DM, Lorenz RA. Pharmacist self-reported antidepressant medication counseling. J Am Pharm Assoc. 2003;53(4):390–399.
37.
Scott DM. Assessment of pharmacists’ perception of patient care competence and need for training in rural and urban areas in North Dakota. J Rural Health. 2010;26(1):90–6.PubMedCrossRef
38.
Giannetti V, Caley CF, Kamal KM, Covvey JR, McKee J, Wells BG, et al. Community pharmacists and mental illness: a survey of service provision, stigma, attitudes and beliefs. Int J Clin Pharm. 2018;40(5):1096–105.PubMedCrossRef
39.
Scheerder G, De Coster I, Van Audenhove C. Pharmacists’ role in depression care: a survey of attitudes, current practices, and barriers. Psychiatr Serv (Washington, DC). 2008;59(10):1155–60.CrossRef
40.
Scheerder G, Van Audenhove C, Arensman E, Bernik B, Giupponi G, Horel AC, et al. Community and health professionals’ attitude toward depression: a pilot study in nine EAAD countries. Int J Soc Psychiatry. 2011;57(4):387–401.PubMedCrossRef
41.
Black E, Murphy AL, Gardner DM. Community pharmacist services for people with mental illnesses: preferences, satisfaction, and stigma. Psychiatr Serv (Washington, DC). 2009;60(8):1123–7.CrossRef
42.
Scheerder G, De Coster I, Van Audenhove C. Community pharmacists’ attitude toward depression: a pilot study. Res Soc Administr Pharm RSAP. 2009;5(3):242–52.CrossRef
43.
Alzubaidi H, Saidawi W, Mc Namara K. Pharmacist views and pharmacy capacity to deliver professional services in the United Arab Emirates. Int J Clin Pharm. 2018.
44.
Bolarinwa OA. Principles and methods of validity and reliability testing of questionnaires used in social and health science researches. Niger Postgrad Med J. 2015;22(4):195–201.PubMedCrossRef
45.
Dillman DA. Mail and internet surveys the tailored design method. 2nd ed. John Wiley & Sons; 2007.
46.
Fagerland MW, Sandvik L, Mowinckel P. Parametric methods outperformed non-parametric methods in comparisons of discrete numerical variables. BMC Med Res Methodol. 2011;11:44.PubMedPubMedCentralCrossRef
47.
Masconi KL, Matsha TE, Echouffo-Tcheugui JB, Erasmus RT, Kengne AP. Reporting and handling of missing data in predictive research for prevalent undiagnosed type 2 diabetes mellitus: a systematic review. Epma j. 2015;6(1):7.PubMedPubMedCentralCrossRef
48.
Kypri K, Samaranayaka A, Connor J, Langley JD, Maclennan B. Non-response bias in a web-based health behaviour survey of New Zealand tertiary students. Prev Med. 2011;53(4–5):274–7.PubMedCrossRef
49.
Greenland S, Daniel R, Pearce N. Outcome modelling strategies in epidemiology: traditional methods and basic alternatives. Int J Epidemiol. 2016;45(2):565–75.PubMedPubMedCentralCrossRef
50.
Greenland S, Pearce N. Statistical foundations for model-based adjustments. Annu Rev Public Health. 2015;36:89–108.PubMedCrossRef
51.
El Hajj MS, Mahfoud ZR, Al Suwaidi J, Alkhiyami D, Alasmar AR. Role of pharmacist in cardiovascular disease-related health promotion and in hypertension and dyslipidemia management: a cross-sectional study in the State of Qatar. J Eval Clin Pract. 2016;22(3):329–40.PubMedCrossRef
52.
Paravattil B, Kheir N, Yousif A. Utilization of simulated patients to assess diabetes and asthma counseling practices among community pharmacists in Qatar. Int J Clin Pharm. 2017;39(4):759–68.PubMedCrossRef
53.
El Hajj MS, Abu Yousef SE, Basri MA. Diabetes care in Qatar: a survey of pharmacists’ activities, attitudes and knowledge. Int J Clin Pharm. 2018;40(1):84–93.PubMedCrossRef
54.
Zolezzi M. Healthcare practitioners’ views of their role in addressing the medical comorbidites of people with mental illness. Int J Psychiat Psychiatr Disord. 2020;4:31–44.
55.
Al-Arifi MN. Community pharmacists attitudes towards mental illness and providing pharmaceutical care for mentally ill patients. Neurosciences (Riyadh, Saudi Arabia). 2008;13(4):412–20.
56.
57.
El Hajj MS, Al-Saeed HS, Khaja M. Qatar pharmacists’ understanding, attitudes, practice and perceived barriers related to providing pharmaceutical care. Int J Clin Pharm. 2016;38(2):330–43.PubMedCrossRef
58.
Babiker AH, Carson L, Awaisu A. Medication use review in Qatar: are community pharmacists prepared for the extended professional role? Int J Clin Pharm. 2014;36(6):1241–50.PubMedCrossRef
59.
Aldahmashi T, Almanea A, Alsaad A, Mohamud M, Anjum I. Attitudes towards depression among non-psychiatric physicians in four tertiary centres in Riyadh. Health Psychol Open. 2019;6(1).
60.
Eltorki Y, Abdallah O, Omar N, Zolezzi M. Perceptions and expectations of health care providers towards clinical pharmacy services in a mental health hospital in Qatar. Asian J Psychiatr. 2019;42:62–66.
61.
Zolezzi M, Bensmail N, Zahrah F, Khaled SM, El-Gaili T. Stigma associated with mental illness: perspectives of university students in Qatar. Neuropsychiatr Dis Treat. 2017;13:1221–33.PubMedPubMedCentralCrossRef
62.
Abi Doumit C, Haddad C, Sacre H, Salameh P, Akel M, Obeid S, et al. Knowledge, attitude and behaviors towards patients with mental illness: Results from a national Lebanese study. PLoS ONE. 2019;14(9):e0222172.PubMedPubMedCentralCrossRef
63.
Vally Z. Mental health stigma continues to impede help-seeking and self-care efforts among trainees in mental health professions. Perspect Psychiatr Care. 2019;55(2):161–2.PubMedCrossRef
64.
Khan N, Kausar R, Khalid A, Farooq A. Gender differences among discrimination & stigma experienced by depressive patients in Pakistan. Pakistan J Med Sci. 2015;31(6):1432–6.
65.
Lauber C, Nordt C, Falcato L, Rössler W. Factors Influencing Social Distance Toward People with Mental Illness. Community Ment Health J. 2004;40(3):265–74.PubMedCrossRef
66.
Angermeyer MC, Dietrich S. Public beliefs about and attitudes towards people with mental illness: a review of population studies. Acta Psychiatr Scand. 2006;113(3):163–79.PubMedCrossRef
67.
Kheir N, Zaidan M, Younes H, El Hajj M, Wilbur K, Jewesson PJ. Pharmacy education and practice in 13 Middle Eastern countries. Am J Pharm Educ. 2008;72(6):133.PubMedPubMedCentralCrossRef
68.
Sewilam AM, Watson AM, Kassem AM, Clifton S, McDonald MC, Lipski R, et al. Suggested avenues to reduce the stigma of mental illness in the Middle East. Int J Soc Psychiatry. 2015;61(2):111–20.PubMedCrossRef
69.
Dipaula BA, Qian J, Mehdizadegan N, Simoni-Wastila L. An elective psychiatric course to reduce pharmacy students’ social distance toward people with severe mental illness. Am J Pharm Educ. 2011;75(4):72.PubMedPubMedCentralCrossRef
70.
Patten SB, Remillard A, Phillips L, Modgill G, Szeto A, Kassam A, et al. Effectiveness of contact-based education for reducing mental illness-related stigma in pharmacy students. BMC Med Educ. 2012;12:120.PubMedPubMedCentralCrossRef
71.
Bell JS, Whitehead P, Aslani P, Sacker S, Chen TF. Design and implementation of an educational partnership between community pharmacists and consumer educators in mental health care. Am J Pharm Educ. 2006;70(2):28.PubMedPubMedCentralCrossRef
Metadata
Title
The role of community pharmacists in depression management: a survey of attitudes, practices and perceived barriers
Authors
Rula Shami
Mohammed Fasihul Alam
Maguy Saffouh ElHajj
Publication date
01-02-2022
Publisher
Springer International Publishing
Published in
International Journal of Clinical Pharmacy / Issue 1/2022
Print ISSN: 2210-7703
Electronic ISSN: 2210-7711
DOI
https://doi.org/10.1007/s11096-021-01337-9

Other articles of this Issue 1/2022

International Journal of Clinical Pharmacy 1/2022 Go to the issue

Commentary

Regulating pediatric off-label uses of medicines in the EU and USA: challenges and potential solutions

Review Article

Impact of mobile health and telehealth technology on medication adherence of stroke patients: a systematic review and meta-analysis of randomized controlled trials

Research Article

Impact of pharmacist-involved collaborative care on diabetes management in a primary healthcare setting using real-world data

Correction

Correction to: Developing a theory‑based behavior change intervention to improve the prescription of surgical prophylaxis

Abstract

Abstracts of the 25th Annual Meeting of ESPACOMP, the International Society for Medication Adherence, 08–19 November 2021

Research Article

Physicians’ perceived barriers and enablers for deprescribing among older patients at public primary care clinics: a qualitative study
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine
Image Credits